Vancouver, British Columbia-Predicting off-treatment time forintermittent androgen suppression is complex and involves manyfactors, said Laurence Klotz, MD, chief, division of urology,Sunnybrook and Women's College Health Sciences Center in Toronto.
How the ongoing shortage of 177Lu-PSMA-617 in the US affects care for patients with prostate cancer
March 28th 2023"Some of these patients newly referred don't have any other proven therapies remaining...This is the only one on the shelf that has a proven benefit. Unfortunately, we can't offer them that at this stage," says Praful Ravi, MD, BChir, MRCP.
2 Clarke Drive
Cranbury, NJ 08512